DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Sabatine MS, Giugliano RP, Wiviott SD et al.
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
N Engl J Med 2015;
372: 1500-1509
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.